DELCATH SYSTEMS, INC. Restructuring and Related Cost, Incurred Cost
DELCATH SYSTEMS, INC. (DCTH) reported Restructuring and Related Cost, Incurred Cost of $403.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostIncurredCost · last filed 2016-03-18
- DELCATH SYSTEMS, INC. restructuring and related cost, incurred cost for fiscal 2015 was $403.00K.
| Period end | Restructuring and Related Cost, Incurred Cost 12 month |
|---|---|
| 2015-12-31 | $403.00K 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| CARLSMED, INC. (CARL) | United States | $0.405B |